首页> Eye (London, England)> Systemic corticosteroid use in UK Uveitis practice: results from the ocular inflammation steroid toxicity risk (OSTRICH) study.

Systemic corticosteroid use in UK Uveitis practice: results from the ocular inflammation steroid toxicity risk (OSTRICH) study.

导出 OA

翻译打印收藏纠错

第一作者： Lorna,Leandro

第一单位： University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.

作者： Lorna,Leandro ^[1] ; Nicholas,Beare ^[2] ; Kanchan,Bhan ^[3] ; Philip I,Murray ^[4] ; Colm,Andrews ^[5] ; Erika,Damato ^[6] ; Alastair K,Denniston ^[7] ; Nitin,Gupta ^[8] ; Periyasamy,Kumar ^[9] ; Archana,Pradeep ^[10] ; Fahd,Quhill ^[11] ; Adam,Ross ^[12] ; Amira,Stylianides ^[2] ; Srilakshmi M,Sharma ^[13] ; Uveitis National Clinical Study Group

作者单位： University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK. ^[1] Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK. ^[2] The Leeds Centre for Ophthalmology, Leeds, UK. ^[3] University of Birmingham, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK. ^[4] Oxford Eye Hospital, Oxford, UK. ^[5] Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. ^[6] University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. ^[7] West Suffolk NHS Foundation Trust, Bury St Edmunds, UK. ^[8] University Hospitals of Leicester NHS Trust, Leicester, UK. ^[9] Nottingham University Hospitals NHS Trust, Nottingham, UK. ^[10] Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, England. ^[11] Bristol Eye Hospital, Bristol, England. ^[12] Oxford Eye Hospital, Oxford University Hospitals NHS Trust, Oxford, England. srilakshmi.sharma@ouh.nhs.uk. ^[13]